Firefly Bio, Inc.
South San Francisco, US · Founded 2022 · 3 known investors
Find your way into Firefly Bio, Inc.
Founders & leadership
Board
JD

PB

TF

AM

PC

Investors · 3
Reported raises · per SEC filings
Form D private placements$40M disclosed across 1 round · 2023
▶$40MraisedMar 2024 · 8 investors · BiotechnologyRule 506(b)
▶$40MraisedMar 2024 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John FlygareExecutive Officer
- Jerel DavisDirector
- Pankaj BhargavaDirector
- Todd FoleyDirector
- Bernhard GeierstangerExecutive Officer
- Alexander MaywegDirector
- Peter ColabuonoDirector
- Scott HirschExecutive Officer, Director
- Offering amount
- $72M
- Amount sold
- $40M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Firefly Bio, Inc.'s investors?
- Firefly Bio, Inc.'s investors include Decheng Capital, MPM BioImpact, Versant Ventures.
- How much funding has Firefly Bio, Inc. raised?
- Firefly Bio, Inc. has disclosed $40M raised across 1 round.
- Where is Firefly Bio, Inc. headquartered?
- Firefly Bio, Inc. is headquartered in South San Francisco, US.


